OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
Adam L. Bailey, Oleksandr Dmytrenko, Lina Greenberg, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 4, pp. 331-345
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 349

SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19
Juan A. Pérez-Bermejo, Michael S. Kang, Sarah J. Rockwood, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 590
Open Access | Times Cited: 200

Cardiovascular complications of COVID-19
Farnaz Farshidfar, Navid Koleini, Hossein Ardehali
JCI Insight (2021) Vol. 6, Iss. 13
Open Access | Times Cited: 132

COVID-19, Myocarditis and Pericarditis
DeLisa Fairweather, Danielle J. Beetler, Damian N. Di Florio, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1302-1319
Open Access | Times Cited: 119

COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 117

Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 103

Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 48

Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 19

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
Xinyu Cui, Wuyue Chen, Haoyan Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 61

Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 49

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients
Marjorie Cornejo Pontelli, Ítalo A. Castro, Ronaldo B. Martins, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 45

Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
Hidenori Tani, Shugo Tohyama
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 43

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment
Aydin Huseynov, İbrahim Akın, Daniel Duerschmied, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 389-389
Open Access | Times Cited: 39

Modeling Heart Diseases on a Chip: Advantages and Future Opportunities
Omar Mourad, Ryan Yee, Mengyuan Li, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 483-497
Closed Access | Times Cited: 37

Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice
Emil Brociek, Agata Tymińska, Andrea Silvio Giordani, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 874-874
Open Access | Times Cited: 28

How Does COVID-19 Affect the Heart?
Lorenzo R. Sewanan, Kevin J. Clerkin, Nathan R. Tucker, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 3, pp. 171-184
Open Access | Times Cited: 23

Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes
Rick Xing Ze Lu, Naimeh Rafatian, Yimu Zhao, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 10

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
Nikhil Kirtipal, Sanjay Kumar, Sumit Kumar Dubey, et al.
Infection Genetics and Evolution (2022) Vol. 99, pp. 105254-105254
Open Access | Times Cited: 33

Persistent viral infections and their role in heart disease
Ashwin Badrinath, Sagar Bhatta, Anna Kloc
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30

Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models
Elisa Mohr, Thomas Thum, Christian Bär
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1778-1791
Open Access | Times Cited: 29

Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions
Disha D. Shah, Neha R. Raghani, Mehul R. Chorawala, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 11, pp. 2861-2880
Open Access | Times Cited: 19

Roles of host proteases in the entry of SARS-CoV-2
Alexandria Zabiegala, Yunjeong Kim, Kyeong‐Ok Chang
Animal Diseases (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top